June 30, 2020
This exciting project was made possible by Health Innovation Manchester Momentum Fund, which was established to support the introduction and adoption of needs-led, evidence-based innovations into the healthcare system within Greater Manchester. Cambio CDS are supporting Professor Richard Body, Consultant in Emergency Medicine on a CDS application called T-MACS.
Chest pain is one of the most common reasons for hospital admission for patients presenting at the Emergency Department, but many of these admissions could be safely avoided with improved diagnostic technology to rapidly rule out acute coronary syndromes (ACS) such as heart attack. Several clinical studies and real-world evaluations show that the Troponin-only Manchester Acute Coronary Syndrome (T-MACS) decision aid accurately identifies those at low risk of heart attack, allowing for more patients to be discharged early.
This project is using the Cambio CDS solution to develop and pilot the T-MACS application within the workflow to allow clinicians to calculate the risk, review recommended course of action and save data for future T-MACS related research.
- Professor Richard Body, Consultant in Emergency Medicine, Honorary Lecturer in Cardiovascular Medicine at Manchester University NHS Foundation Trust, said: “This collaboration with Cambio CDS is crucial to ensure that our current endeavours remain fully compliant with changing regulations and to make the project scalable. The platform provided by Cambio CDS would enable hospitals across the world to rapidly adopt efficient clinical pathways to care for patients with chest pain, optimising patient care and reducing unnecessary use of precious healthcare resources.”
- Dr Rong Chen, Cambio CDS CEO, said: “As Cambio CDS we are very pleased to have this opportunity to continue working with the NHS. Professor Body’s T-MACS solution is a wonderful application that has real impact for patient care and reducing unnecessary hospital admissions. We look forward to continue working with Professor Body and his team to ensure that T-MACS is seamlessly embedded in the Hospital System workflow with our EHR independent Clinical Decision Support (CDS) Solution.”
Health Innovation Manchester (HInM) is responsible for accelerating proven innovation into Greater Manchester’s health and social care services. HInM brings together health, academia and industry as part of an academic health science system with the aim of accelerating innovation to improve people’s health and wellbeing – they selected the winners of the Momentum Fund with the help of a panel of representatives from patients and partners.